Section 21

EQS-News: Holdco B147402 S.A. (formerly VIC Properties S.A.): Update on the Consent Solicitation Process – Results of Noteholders' Meeting held on 11 October

Retrieved on: 
Tuesday, October 17, 2023
ACT, TIMELY, Person, THIS, AS, Communication, ARE, OF, Regulation, FINANCIAL, NOTES, Section 21, ALL, OR, Sale, AFRICA, News, Failure, Condition, FSMA, EACH, Security (finance), Property management, Issuer

IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUIRED TO EXPEDITE TRANSMISSION HEREOF TO BENEFICIAL OWNERS OF THE NOTES IN A TIMELY MANNER.

Key Points: 
  • IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUIRED TO EXPEDITE TRANSMISSION HEREOF TO BENEFICIAL OWNERS OF THE NOTES IN A TIMELY MANNER.
  • As part of the Consent Solicitation, the Issuer held a noteholders' meeting on Wednesday, 11 October 2023 in Berlin, Germany ("Noteholders' Meeting"), the Noteholders' Meeting approved the changes to the Terms and Conditions as proposed in the Consent Solicitation Memorandum.
  • Each Noteholder is solely responsible for making its own independent appraisal of all matters as such Noteholder deems appropriate.
  • Nothing in this announcement constitutes a solicitation in any circumstances in which such solicitation is unlawful.

EQS-News: VIC Properties S.A.: Announcement of New Date for Noteholders Meeting and Redemption

Retrieved on: 
Tuesday, August 22, 2023
ACT, Communication, AS, Failure, Person, OF, EACH, News, FINANCIAL, NOTES, OR, FSMA, ARE, ALL, THIS, Bond (finance), Regulation, AFRICA, Section 21, TIMELY, Sale, Solicitation, Security (finance), Property management, Cryptocurrency, Note, Issuer

-------------------------

Key Points: 
  • As part of the Consent Solicitation, the Issuer has previously scheduled a noteholders' meeting to be held on 22 August 2023 in Berlin, Germany.
  • As the Issuer continues to communicate with Noteholders to enable active participation in the Consent Solicitation, the date for the noteholders' meeting has been rescheduled to 14 September 2023.
  • As the Consent Solicitation would, if successful, extend the maturity date of the Notes, the redemption of the Notes will be delayed beyond the Redemption Date as currently defined (i.e.
  • 24 August 2023) until after the results of the Consent Solicitation Process are final upon the holding of the noteholders' meeting on 14 September 2023.

Owens-Brockway Glass Container Inc. and OI European Group B.V. Announce Results of Cash Tender Offers for Any and All of Certain Outstanding Senior Notes

Retrieved on: 
Wednesday, May 24, 2023
Communication, Person, Investment, Risk, Wells Fargo, Transport, Financial Services and Markets Act 2000, Perception, FSMA, Social Security Government Pension Offset, Expiration, Security (finance), Social, Safety, J. P. Morgan, Personal Information Agent, Uncertainty, Social conditioning, Interest, Settlement date, Direct participation program, COVID-19, Finance, Terrorism, Information, Holder, Documentation, Biophysical environment, Glass, WalletHub, Offers, Section 21, Financial services, Expiration date, Eric Holder, Recycling, Date, Tender, United Kingdom, Weather, OI, Life insurance, Cryptocurrency, Risk management, Note

The deadline to withdraw Notes validly tendered in the Offers was 5:00 p.m., New York City time, on May 23, 2023 (the “Withdrawal Date”).

Key Points: 
  • The deadline to withdraw Notes validly tendered in the Offers was 5:00 p.m., New York City time, on May 23, 2023 (the “Withdrawal Date”).
  • The acceptance of tendered Notes will be made in accordance with the terms of the Offers as described in the Offers to Purchase.
  • Interest will cease to accrue on the applicable Settlement Date for all Notes accepted in the Offers, including those tendered through the Guaranteed Delivery Procedures.
  • King & Co., Inc. has been appointed as the Tender Agent and Information Agent for the Offers.

SASOL ISSUES US DOLLAR SENIOR NOTES

Retrieved on: 
Friday, April 28, 2023
Note, NOT, FOR, Markets in Financial Instruments Directive 2014, KID, European Union (Withdrawal) Act 2018, Section 21, Bank statement, MUFG, SEC Rule 144A, IMI, BofA Securities, Mizuho Securities, SMBC Nikko Securities, Finance, Person, Sale, Prospectus, Documentation, Investment, Sasol, European Economic Area, Citigroup, United Kingdom, Standard Chartered, J. P. Morgan, Security (finance), EEA, EU, Issuer, Regulation

JOHANNESBURG, April 28, 2023 /PRNewswire/ -- Sasol Limited is pleased to announce that its wholly owned subsidiary Sasol Financing USA LLC (the Issuer) has priced an offering of US$-denominated, Rule 144A / Regulation S notes, being US$1 000 million of notes due 2029 (the Notes). The Notes will bear interest at a rate of 8.750% per annum. The orderbook peaked above US$2,3 billion, which represents an oversubscription of more than 2,3 times.

Key Points: 
  • JOHANNESBURG, April 28, 2023 /PRNewswire/ -- Sasol Limited is pleased to announce that its wholly owned subsidiary Sasol Financing USA LLC (the Issuer) has priced an offering of US$-denominated, Rule 144A / Regulation S notes, being US$1 000 million of notes due 2029 (the Notes).
  • The Notes will bear interest at a rate of 8.750% per annum.
  • The Notes will be general unsecured obligations of the Issuer and will be fully and unconditionally guaranteed by Sasol Limited.
  • As a result of this transaction we have now fully pre-funded our March 2024 bond maturity, and this follows the recent extension of our US dollar loan maturity to 2028," said Hanré Rossouw, Chief Financial Officer, Sasol Limited.

aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting

Retrieved on: 
Monday, April 17, 2023
NRP2, AACR, VEGF-C, Section 21, Small RNA, ATyr Pharma, Neoplasm, Lymphatic system, Glomus tumor, Neuropilin, Lung cancer, Renal cell carcinoma, VEGF, SAN, VEGFR, Cancer, Annual general meeting, Biology, Growth, Poster, Metastasis, Medical imaging, Research

Treatment with ATYR2810 monotherapy and in combination with chemotherapy in a model of non-small cell lung cancer demonstrated increased tumor growth inhibition and sensitivity to chemotherapy.

Key Points: 
  • Treatment with ATYR2810 monotherapy and in combination with chemotherapy in a model of non-small cell lung cancer demonstrated increased tumor growth inhibition and sensitivity to chemotherapy.
  • In a model of clear cell renal cell carcinoma, ATYR2810 in combination with the VEGFR-targeted therapy sunitinib inhibited tumor growth and led to tumor regression in some cases.
  • These data demonstrate the potential therapeutic effects of blocking the NRP2/VEGF-C signaling axis with ATYR2810 on enhanced tumor growth inhibition and sensitivity to chemotherapy and targeted therapy.
  • ATYR2810 is in preclinical development for the treatment of aggressive cancers where NRP2 is implicated.

ZielBio to Present New Research on the Utility of Cancer-Specific Plectin (CSP) and ZB131 in Antibody-Drug Conjugates at AACR Annual Meeting 2023

Retrieved on: 
Monday, April 17, 2023
Human, AACR, Section 21, Cancer, Pharmacokinetics, American Association for Cancer Research, ISCB Senior Scientist Award, Spacecraft, CSP, Pharmaceutical industry, Vaccine, Research

CHARLOTTESVILLE, Va., April 17, 2023 /PRNewswire/ -- ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases, will present new, preclinical data showing that its lead asset, ZB131, directed against cancer-specific plectin (CSP), represents a promising approach for antibody-drug conjugates (ADCs) at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Key Points: 
  • The AACR Annual Meeting is taking place April 14-19, 2023 in Orlando and virtually.
  • ZielBio has validated CSP, a pro-tumorigenic protein expressed on the surface of cancer cells, as a high-value drug target and developed ZB131 as a first-in-class anti-CSP monoclonal antibody.
  • ZB131 demonstrates favorable pharmacokinetics, is rapidly internalized by CSP-expressing tumor cells in mouse models, and can be conjugated to multiple cytotoxic payloads.
  • "We are excited to share this data with the AACR community and are committed to exploring new avenues for deploying ZB131 against difficult-to-treat cancers."

Canadian Pacific announces results of early tenders of Kansas City Southern notes

Retrieved on: 
Monday, April 3, 2023
Exercise, Attention, EEA, Communication, Note, Markets in Financial Instruments Directive 2014, Financial Services and Markets Act 2000, Section 21, Financial services, European Union (Withdrawal) Act 2018, Telephone, Person, Expiration date, KCS, FSMA, Exchange, Relevance (Person of Interest), Finance, Old, Judgement, II, Sale, Register, CPRC, Prospectus, Expiration, Trust, European Economic Area, Initial exchange offering, Corporation, Registration statement, Control, Relevant, United Kingdom, CPRL, Security (finance), EU, Canadian Pacific Railway, Regulation

The CPRC Notes are expected to be issued promptly on or about the second business day following the Expiration Date (the "Settlement Date").

Key Points: 
  • The CPRC Notes are expected to be issued promptly on or about the second business day following the Expiration Date (the "Settlement Date").
  • CPRL's exercise of control of KCS is not conditioned upon the commencement or completion of the Exchange Offers.
  • The Registration Statement relating to the CPRC Notes has been filed with the SEC but has not yet become effective.
  • To validly tender the Old Notes, holders of Old Notes in Canada must complete, sign and submit to the exchange agent a Canadian eligibility statement in the form appended to the Canadian offering memorandum.

EQS-News: Vonovia SE: Final Results of Tender Offer for 2023 & 2024 Bonds

Retrieved on: 
Sunday, November 27, 2022
Regulation, Internet, AMERICA, ITS, United Kingdom, Luxembourg Stock Exchange, Hand, Republic, Telephone, Financial Services and Markets Act 2000, WAKE, Financial services, ISLAND, ANY, Documentation, Person, News, Section 21, Advertising, Security (finance)

1bn across 8 bonds maturing in 2023 and 2024 were validly tendered and accepted for repurchase.

Key Points: 
  • 1bn across 8 bonds maturing in 2023 and 2024 were validly tendered and accepted for repurchase.
  • The settlement of the tender offer is expected to take place on November24.
  • Vonovia remains fully committed towards the other elements of the liability management, as communicated with the 9M 2022 results.
  • The new notes issued by Vonovia are not being, and will not be, offered or sold in the United States.

BMC ANNOUNCES EARLY RESULTS FOR CASH TENDER OFFER FOR OUTSTANDING NOTES

Retrieved on: 
Tuesday, August 30, 2022
Holder, Islamic Financial Services Act 2013, Software, Disclosure, Financial Services and Markets Authority (Belgium), Organization, European Economic Area, Company, Finance, Financial Services Act, Commissione Nazionale per le Società e la Borsa, Time, Sale, Legislature, European Economic Area Family Permit, SIX, Information, Communication, Investment, BMC Software, BMC, Urban economics, Person, Digital Enterprise Research Institute, Republic, Financial services, FSMA, News, United Kingdom, Swiss Financial Market Supervisory Authority, CONSOB, Swiss Code of Obligations, Patent, Forbes, Section 21, Tender, Compliance, Security (finance), Note, Offer, Swiss

This news release does not constitute an offer to buy or the solicitation of an offer to sell Notes (and tenders of Notes in the Offer will not be accepted from Holders) in any circumstances in which such offer or solicitation is unlawful.

Key Points: 
  • This news release does not constitute an offer to buy or the solicitation of an offer to sell Notes (and tenders of Notes in the Offer will not be accepted from Holders) in any circumstances in which such offer or solicitation is unlawful.
  • Any tender of Notes for purchase pursuant to the Offer from a Holder that is unable to make these representations will not be accepted.
  • BMC works with 86% of the Forbes Global 50 and customers and partners around the world to create their future.
  • BMC, BMC Software, the BMC logo, and other BMC marks are the exclusive properties of BMC Software, Inc. and are registered or may be registered with the U.S. Patent and Trademark Office or in other countries.

Gabelli Merger Plus+ Trust plc Update on Share Purchase Offer

Retrieved on: 
Wednesday, August 17, 2022
Banking, Professional Services, Finance, Investment, Board, Loyalty, Financial services, Person, Registered, Circular, EU, RNS, News, Regulation, Financial Services and Markets Act 2000, Securities Act of 1933, Sale, GMP, Nature, Business Process Framework (eTOM), Portfolio manager, United Kingdom, LTD, Offering circular, LLC, European Economic Area, Compliance, Income, Finance, Trustee, Mario Gabelli, Time, Mass meeting, Common stock, Review, Company, Prognosis, Section 21, FSMA, General officer, Forward, Admission, Completeness, EEA, Pharmaceutical industry, Security (finance), Management, Risk management, Property management, Real estate, Bank, Directive 2014/65/EU

Gabelli Funds, LLC, the investment adviser of Gabelli Merger Plus+ Trust plc (the Company), is providing shareholders, as general information, certain details of the Companys tender offer to purchase certain Ordinary Shares (Offer) in advance of publication of the Offering Circular (Circular), and follows the Companys March 23, 2022 announcement.

Key Points: 
  • Gabelli Funds, LLC, the investment adviser of Gabelli Merger Plus+ Trust plc (the Company), is providing shareholders, as general information, certain details of the Companys tender offer to purchase certain Ordinary Shares (Offer) in advance of publication of the Offering Circular (Circular), and follows the Companys March 23, 2022 announcement.
  • Shareholders should contact Gabelli Funds at [email protected] to ensure their necessary evidentiary supporting materials are satisfactory and for any general assistance.
  • The Gabelli Merger Plus+ Trust (GMP) was launched in July 2017 to access Gabellis long term efforts in merger investing.
  • The investment backdrop for the Gabelli Merger Plus+ Trust is robust and positively oriented for returns.